Big Pharma Chooses China over India

Weak Patent Laws Keep Multinationals Away The Indian Daily noted that, over the past two years, five multinational pharmas have announced their intentions to set up R&D facilities in China, not India. Weak patent protection has been the reason, according to the newspaper.In one significant respect, it would be more economic for the companies to establish facilities in India, because many of the drugs being developed are remedies for tropical diseases or those of developing nations. More details...